RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling
- PMID: 29244796
- PMCID: PMC6174252
- DOI: 10.1038/pr.2017.309
RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling
Abstract
BackgroundAlthough rhinovirus infection is associated with increased risks of acute and chronic respiratory outcomes during childhood compared with respiratory syncytial virus (RSV), the underlying mechanisms remain unclear. We aimed to determine the differences in nasal airway microRNA profiles and their downstream effects between infants with rhinovirus and RSV bronchiolitis.MethodsAs part of a multicenter cohort study of infants hospitalized for bronchiolitis, we examined nasal samples obtained from 16 infants with rhinovirus and 16 infants with RSV. We tested nasal airway samples using microarrays to profile global microRNA expression and determine the predicted regulation of targeted transcripts. We also measured gene expression and cytokines for NFκB pathway components.ResultsBetween the virus groups, 386 microRNAs were differentially expressed (false discovery rate (FDR)<0.05). In infants with rhinovirus, the NFκB pathway was highly ranked as a predicted target for these differentially expressed microRNAs compared with RSV. Pathway analysis using measured mRNA expression data validated that rhinovirus infection had upregulation of NFκB family (RelA and NFκB2) and downregulation of inhibitor κB family. Infants with rhinovirus had higher levels of NFκB-induced type-2 cytokines (IL-10 and IL-13; FDR<0.01).ConclusionIn infants with bronchiolitis, rhinovirus and RSV infections had different nasal airway microRNA profiles associated with NFκB signaling.
Conflict of interest statement
Competing interests:
Dr. Mansbach has provided bronchiolitis-related consultation for Regeneron. Dr. Piedra received research grants from Gilead, Janssen Vaccines and Prevention, Novavax, and Regeneron, and provided bronchiolitis-related consultation for Ablynx, LFB, MedImmune, Novavax, and Regeneron. The other authors have no financial relationships relevant to this article to disclose.
Personal financial interests:
Dr. Mansbach has provided bronchiolitis-related consultation for Regeneron. Dr. Piedra received research grants from Gilead, Janssen Vaccines and Prevention, Novavax, and Regeneron, and provided bronchiolitis-related consultation for Ablynx, LFB, MedImmune, Novavax, and Regeneron. The other authors have no financial relationships relevant to this article to disclose.
Figures
Similar articles
-
Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis.Front Immunol. 2024 Feb 12;15:1330991. doi: 10.3389/fimmu.2024.1330991. eCollection 2024. Front Immunol. 2024. PMID: 38410509 Free PMC article.
-
Clinical and Th1/Th2 immune response features of hospitalized children with human rhinovirus infection.J Med Virol. 2020 Jan;92(1):26-33. doi: 10.1002/jmv.25587. Epub 2019 Sep 18. J Med Virol. 2020. PMID: 31475732 Free PMC article.
-
Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity.J Clin Virol. 2018 May;102:101-109. doi: 10.1016/j.jcv.2018.03.003. Epub 2018 Mar 10. J Clin Virol. 2018. PMID: 29549834
-
Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing.Eur Respir J. 2015 Mar;45(3):774-89. doi: 10.1183/09031936.00062714. Epub 2014 Oct 30. Eur Respir J. 2015. PMID: 25359340 Review.
-
Rhinovirus-induced bronchiolitis and asthma development.Pediatr Allergy Immunol. 2011 Jun;22(4):350-5. doi: 10.1111/j.1399-3038.2011.01170.x. Pediatr Allergy Immunol. 2011. PMID: 21535176 Review.
Cited by
-
Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis.Front Immunol. 2024 Feb 12;15:1330991. doi: 10.3389/fimmu.2024.1330991. eCollection 2024. Front Immunol. 2024. PMID: 38410509 Free PMC article.
-
Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: a multicentre prospective study.Eur Respir J. 2023 Aug 3;62(2):2300502. doi: 10.1183/13993003.00502-2023. Print 2023 Aug. Eur Respir J. 2023. PMID: 37321621 Free PMC article.
-
The Host Non-Coding RNA Response to Alphavirus Infection.Viruses. 2023 Feb 18;15(2):562. doi: 10.3390/v15020562. Viruses. 2023. PMID: 36851776 Free PMC article. Review.
-
Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.Allergy. 2022 Nov;77(11):3350-3361. doi: 10.1111/all.15390. Epub 2022 Jun 5. Allergy. 2022. PMID: 35620861 Free PMC article.
-
Air pollution, bronchiolitis, and asthma: the role of nasal microRNAs.Lancet Respir Med. 2022 Aug;10(8):733-734. doi: 10.1016/S2213-2600(22)00133-3. Epub 2022 May 17. Lancet Respir Med. 2022. PMID: 35594872 Free PMC article. No abstract available.
References
-
- Hasegawa K, Mansbach JM, Camargo CA Jr. Infectious pathogens and bronchiolitis outcomes. Expert Rev Anti Infect Ther 2014;12(7):817–28. - PubMed
-
- Foster PS, Plank M, Collison A, et al. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunological reviews. 2013;253(1):198–215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
